Research Studies

D-chiro-inositol Research Studies

Two studies, one with obese and one with lean women with PCOS, were published in 1999 and 2002, respectively. Chiral Balance strongly encourages anyone interested in D-chiro-inositol to read this DCI research and to use it to make informed decsisions.

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome (1999)

Department of Medicine, Medical College of Virginia, Virginia,Commonwealth University, Richmond, Virginia, USA.

CONCLUSIONS: D-chiro-inositolincreases the action of insulin in patients with the polycystic ovary syndrome, thereby improving ovulatory function and decreasing serum androgen concentrations, blood pressure, and plasma triglyceride concentrations.

Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome (2002)

Department of Medicine, Medical College of Virginia, Virginia,Commonwealth University, Richmond, Virginia, USA.

CONCLUSION: We conclude that, in lean women with the polycystic ovary syndrome, D-chiro-inositolreduces circulating insulin, decreases serum androgens, and ameliorates some of the metabolic abnormalities (increased blood pressure and hypertriglyceridemia) of syndrome X.

More About Chiral Balance

Chiral Balance strives to make information about D-chiro-inositol accesible to customers.

Please print out our D-chiro-inositol brochure and doctor pamplet. Ask your doctor for more information about what D-chiro-inositol (DCI) can do for you.